CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape
| Title: | CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape |
|---|---|
| Authors: | Chaudhary, NayanAff1; Chibly, Alejandro M.Aff2; Collier, AnnAff3; Martinalbo, JorgeAff4; Perez-Moreno, PabloAff5; Moore, Heather M.Aff3; Luhn, PatriciaAff1; Metcalfe, CiaraAff6; Hafner, MarcAff2, Aff6, IDs41523024006177_cor9 |
| Source: | npj Breast Cancer. 10(1) |
| Database: | Springer Nature Journals |